Different sensitivity of germinal center B cell-like diffuse large B cell lymphoma cells towards ibrutinib treatment

BACKGROUND: Although rituximab in the combination of CHOP chemotherapy has been widely used as the standard treatment for several kinds of B-cell non-Hodgkin lymphoma (B-NHL), a great number of B-NHL patients treated with this immunotherapy still develop primary and secondary resistance. Recently Br...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Zheng, Xiaohui, Ding, Ning, Song, Yuqin, Feng, Lixia, Zhu, Jun
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2014
נושאים:
Primary Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3984027/
https://ncbi.nlm.nih.gov/pubmed/24693884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-14-32
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים